US · Healthcare

Axim Biotechnologies Inc (AXIM)

Biotechnology

Axim Biotechnologies Inc (AXIM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AXIM

P/E ratio

18.00

Axim Biotechnologies Inc (AXIM) — FAQ

What is AXIM's P/E ratio?

The price-to-earnings (P/E) ratio for Axim Biotechnologies Inc (AXIM) is 18.00 (data as of 2026-03-23).

Does Axim Biotechnologies Inc pay a dividend?

Dividend yield is not available in the current snapshot for Axim Biotechnologies Inc (AXIM). Check the MyAverix Finance app for the latest dividend data.

What sector is Axim Biotechnologies Inc in?

Axim Biotechnologies Inc (AXIM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AXIM listed on?

AXIM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)